Delta Investment Management, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 145 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
Delta Investment Management, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q2 2020$47,000
-25.4%
14,459
-44.2%
0.02%
-58.3%
Q1 2020$63,000
-58.8%
25,918
-20.2%
0.05%
-14.3%
Q4 2019$153,000
+39.1%
32,475
+25.3%
0.06%
-1.8%
Q3 2019$110,00025,9180.06%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2019
NameSharesValueWeighting ↓
MSD Partners, L.P. 15,151,516$38,182,0007.99%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 10,406,850$26,225,0004.02%
MILLER VALUE PARTNERS, LLC 12,385,586$31,211,0001.12%
CHIRON CAPITAL MANAGEMENT, LLC 201,470$508,0000.41%
Sargent Investment Group, LLC 289,025$728,0000.26%
MAGNOLIA CAPITAL ADVISORS LLC 80,542$404,0000.16%
XTX MARKETS LLC 11,086$28,0000.14%
Virtus ETF Advisers LLC 99,108$250,0000.13%
Old West Investment Management, LLC 210,226$529,0000.12%
EQUITEC PROPRIETARY MARKETS, LLC 31,300$79,0000.06%
View complete list of ZIOPHARM ONCOLOGY INC shareholders